Final height in patients perinatally infected with the human immunodeficiency virus

S Stagi1, L Galli, C Cecchi

  • 1Department of Paediatrics, Anna Meyer Children's University Hospital, Florence, Italy. stefano.stagi@yahoo.it

Insights

Children with perinatal human immunodeficiency virus (HIV) infection often have reduced final height compared to their target height. Accumulated growth deficits during childhood and adolescence may contribute to this reduced final height in HIV-infected individuals.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Endocrinology

Background:

  • Final height data are lacking for children with human immunodeficiency virus (HIV) infection.
  • Understanding growth patterns in HIV-infected children is crucial for clinical management.

Purpose of the Study:

  • To evaluate auxological data up to final height in a cohort of perinatally HIV-infected children.
  • To determine factors influencing final height in this population.

Main Methods:

  • Retrospective analysis of auxological data in 95 Caucasian patients (median age 17.5 years) with perinatal HIV infection.
  • Evaluation of prepubertal height (PrH), height velocity (HV), final height (FH), target height (TH), and predicted adult height (PAH) as standard deviation (SD) scores.

Main Results:

  • Patients exhibited significantly reduced PrH and FH compared to their TH (p < 0.001).
  • Age at puberty onset correlated negatively with PrH (p = 0.002) and CD4+ cell percentage (p < 0.01).
  • Height velocity (HV) correlated significantly with viremia (p = 0.001) but not CD4+ cell percentage.

Conclusions:

  • Perinatally HIV-infected patients achieve a final height significantly reduced and not aligned with their target height.
  • Growth deficits accumulated during childhood and adolescence appear to contribute to reduced final height in HIV-infected children.
Abstract

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...